Replies to post #23679 on GOOD TRADERS FORUM

[powerbattles]

$QNTA PENDING Escozine FDA IND APPROVAL in 3 days.

QNTA Tiny SS, O/S reducing. Quanta owned multi patents. Its rare to see a biotech company on Pinkyland actual reporting earnings millions of dollars. Quanta is still under radar, might becoming a runner like VXRT, OCGN or GNUS from penny to dollars. Imho:))

This is the moment we've been waiting for IND FDA approval.

[/quote]announced today that it has filed its final set of data requested by the US Food and Drug Administration (FDA) for its Pre-Investigational New Drug (PIND #150335) filing on its lead drug candidate Escozine® as a COVID-19 therapeutic. Along with the submission of a batch of Escozine® previously announced specifically produced for the FDA, the Company believes that this will be the last submission necessary in order to receive IND designation from the regulatory body in the United States. [/quote]
https://www.globenewswire.com/news-release/2021/04/13/2209126/0/en/Medolife-Rx-Submits-Final-Data-Set-to-FDA-for-IND-Filing-on-Lead-Drug-Candidate.html

Escozine-HP™ Pretty Pricey and it's Truly a Cancer Cure...

https://escozine.net/

https://medolife.com/escozine-hp/

Medolife Rx Implements Proprietary Electro Solution, Further Increasing Efficacy of Polarization Technology
May 06, 2021 08:00 ET | Source: Quanta, Inc.

https://www.globenewswire.com/news-release/2021/05/06/2224499/0/en/Medolife-Rx-Implements-Proprietary-Electro-Solution-Further-Increasing-Efficacy-of-Polarization-Technology.html

$QNTA All News

https://www.globenewswire.com/en/search/organization/Quanta%CE%B4%2520Inc%C2%A7

Chart looks poised for reversals